The Odisha government unveiled the Pharmaceutical and Medical Devices Policy-2025 on Tuesday, setting an ambitious target to attract an investment of Rs 25,000 crore and generate 1 lakh jobs by 2030.
Chief Minister Mohan Charan Majhi launched the new policy in Bhubaneswar at the Odisha Pharma Summit-2025 in the presence of Industries Minister Sampad Chandra Swain and senior government officers.
Speaking on the occasion, Industries Department’s Additional Chief Secretary Hemant Sharma highlighted the significant market opportunity, noting that India currently imports about 85 per cent of medical devices from other countries.
Given the expected increase in pharmaceutical and medical device units over the next five years, he stressed that Odisha must strive to be a key participant in this endeavor.
Under the Pharmaceutical and Medical Devices Policy-2025, the state offers attractive incentives, including a 50 per cent subsidy on concessional land cost for units that employ more than 200 Odisha-domiciled skilled staff.
The government also offered a 30 per cent capital subsidy on eligible plant and machinery (disbursed up to 6 per cent per annum for 5 years), notably without any upper cap, while a 25 per cent subsidy (capped at Rs 1 crore) will be given for dedicated power infrastructure, another official said.
The objective of the new policy is to fast-track Odisha as the eastern hub for pharmaceuticals and medical devices through investment, jobs, innovation, and green manufacturing, he stated.
“The policy is expected to bring an investment of Rs 25,000 crore and generate direct and indirect employment for 1 lakh individuals by 2030,” he said. MoUs worth Rs 5,000 crore have been signed on Tuesday itself, the official said.
The policy also aims to attract investment and catalyse local entrepreneurship and MSME growth, while generating employment across skilled and semi-skilled segments.
Anchored in the state’s Industrial Policy Resolution (IPR) – 2022, which identifies pharmaceuticals, bulk drugs, and medical devices as a thrust sector, the policy promotes infrastructure readiness, research excellence, industry–academia collaboration for skilling and a facilitative regulatory environment to enable inclusive and sustainable industrial development, another official said.
The state will set up an Odisha Pharma Park and an Odisha MedTech Park (over 200 acres each) as integrated, good manufacturing practices (GMP)-ready clusters, he said.
The policy combines land, finance, skilled workforce, regulatory facilitation and R&D support to attract anchor investments across active pharmaceutical ingredients (APIs), formulations, vaccines, diagnostics, imaging, implants and wearables – positioning Odisha as a competitive, sustainable manufacturing and innovation destination.
It covers pharmaceuticals – APIs, bulk drugs, formulations, vaccines, biologicals and biosimilars, veterinary drugs and animal vaccines, nutraceuticals, and cosmetics classified as drugs; and Medical Devices – in-vitro diagnostics (IVD), implants, surgical consumables, instruments and apparatus, medical wearables, digital health devices and device software, the official added.
